PET/CT appearance of desmoid tumour of the chest wall

British Journal of Radiology

Volumn 83, Issue 986, 2010, Pages

  Souza, Frederico F ^a,b   Fennessy, F M ^a,b   Yang, Q ^b   Van Den Abbeele, A D ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; GADOLINIUM PENTETATE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; BREAST CANCER; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DESMOID TUMOR; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSICAL EXAMINATION; RECURRENT CANCER; THORAX WALL; TUMOR BIOPSY; BIOPSY; FIBROMATOSIS; POSITRON EMISSION TOMOGRAPHY; SECOND CANCER;

AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROMATOSIS, AGGRESSIVE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THORACIC WALL;

EID: 76149110455     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/18648939     Document Type: Article

References (14)

1. Dominguez-Malagon HR, Alfeiran-Ruiz A, Chavarria-Xicotencatl P, Duran-Hernandez MS. Clinical and cellular effects of colchicine in fibromatosis. Cancer 1992;69:2478-83.
2. Eubank WB, Mankoff DA. Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 2005;35:84-99.
3. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim E. Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging. Radiology 2007;245:839-47.
4. Chapelier AR, Bacha EA, de Montpreville VT, Dulmet EM, Rietjens M, Margulis A, et al. Radical resection of radiationinduced sarcoma of the chest wall: report of 15 cases. Ann Thorac Surg 1997;63:214-19.
5. Tateishi U, Gladish G, Kusumoto M, Hasegawa T, Tsuchiya R, Moriyama N, et al. Chest wall tumors: radiologic findings and pathologic correlation: part 1. Benign tumors. Radiographics 2003;23:1477-90.
6. Tateishi U, Gladish GW, Kusumoto M, Hasegawa T, Tsuchiya R, Moriyama N, et al. Chest wall tumors: radiologic findings and pathologic correlation: part 2. Malignant tumors. Radiographics 2003;23:1491-508.
7. O'Sullivan P, O'Dwyer H, Flint J, Munk P, Muller N. Soft tissue tumours and mass-like lesions of the chest wall: a pictorial review of CT and MR findings. Br J Radiol 2007;80:574-80.
8. Kinzbrunner B, Ritter S, Domingo J, Rosenthal CJ. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 1983;54:2011-14.
9. Tsuchishima S, Nishizawa H, Matsumoto Y, Kitagawa S, Shimizu T, Yuasa K. A desmoid tumor of the chest wall. Kyobu Geka 1998;51:1055-9.
10. Kabiri EH, Al Aziz S, El Maslout A, Benosman A. Desmoid tumors of the chest wall. Eur J Cardiothoracic Surg 2001;19:580-3.
11. Klein DL, Gamsu G, Gant TD. Intrathoracic desmoid tumor of the chest wall. AJR Am J Roentgenol 1977;129:524-5.
12. Munden RF, Kemp BL. Desmoid tumor of the chest wall. Am J Roentgenol 1999;172:1149.
13. Pierce, JC, Henderson R. Hypermetabolism of elastofibroma dorsi on PET-CT. Am J Roentgenol 2004;183:35-7.
14. Basu S, Nair N, Banavali S. Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management. Br J Radiol 2007;957:750-6.